About Biologics
Aims
Biologics (ISSN 2673-8449) provides an advanced forum for findings on all aspects of biologics derived from both novel and established biotechnologies. It publishes reviews, research papers, and communications in all areas of biologicals and at the interface of related disciplines. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the maximum length of the papers. Full experimental and/or methodical details must be provided so that the results can be reproduced. Electronic files or software regarding the full details of the calculation and experimental procedure – if impossible to publish in a normal way – can be deposited as supplementary material.
Subject Areas
This journal covers all topics related to biologics. Topics of interest include but are not limited to the following:
Vaccines
- Bacterial vaccines
- Viral vaccines
- Tumor vaccines
Hormones
- Insulin
- Glucagon
- Growth hormone
- Gonadotrophins
Cytokines and allied mediators
- Interleukins and Interleukin-based products (Interleukin-2)
- Interferons (Interferons-α, -β, -γ)
- Tumor necrosis factors
- Chemokinefamily
- Hematopoietic growth factors (Erythropoietin, colony-stimulating factors)
Diagnostics
- Radiology
- Nuclear medicine
- Medical imaging
- Endoscopy
- Pathology
- Biopsy
- Molecular diagnostics
- Medical screening
- Biomarkers
- Diagnostic microbiology and infectious disease
- Point-of-care testing and devices
Gene therapies
- Somatic gene therapies
- Germline gene therapies
Cytology
- Living cells used in cell therapy
- Cell culture technology
- Cellular immunology
Tissues
Thrombolytic agents (tissue plasminogen activator)
Monoclonal antibodies (Various)
Blood and blood components
Allergenics
Downstream processing
General bacteriology
General virology, endogenous, and adventitious viruses
Molecular biology
Parasitology
Prion and prion disease
Protein chemistry
Toxins
Toxoids
Resources:
- Human
- Animal
- Plant
- Fungus
- Microorganism
MDPI Publication Ethics Statement
MDPI is a member of the Committee on Publication Ethics (COPE).
MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add
high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate
authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in
such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.
Book Reviews
Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.
MDPI
St. Alban-Anlage 66
CH-4052 Basel
Switzerland
Copyright / Open Access
Articles published in Biologics will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text:
Reprints may be ordered. Please contact for more information on how to order reprints. Announcements regarding academic activities such as conferences are published for free in the News & Announcements section of the journal. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is . For further MDPI contacts, see here.Reprints
Announcement and Advertisement
Editorial Office
Contact us
